The expression of a nitric oxide derivative, tissue inhibitors of metalloproteinase-3, and tissue inhibitors of metalloproteinase-4 in chronic periodontitis with type 2 diabetes mellitus

키워드

참고문헌 (39)

1. Eley BM, "Proteolytic and hydrolytic enzymes from putative periodontal pathogens: characterization, molecular genetics, effects on host defenses and tissues and detection in gingival crevice fluid", Periodontol 2000, 31, pp.105~124 (2003)
2. Hou YC, "Current trends in the development of nitric oxide donors", Curr Pharm Des, 5, pp.417~441 (1999)
3. Batista AC, "Nitric oxide synthesis and severity of human periodontal disease", Oral Dis, 8, pp.254~260 (2002)
4. Abramson SB, "The role of nitric oxide in tissue destruction", Best Pract Res Clin Rheumatol, 15, pp.831~845 (2001)
5. Reher VG, "Nitric oxide levels in saliva increase with severity of chronic periodontitis", J Oral Sci, 49, pp.271~276 (2007)
6. Kendall HK, "Nitric oxide and tissue destruction", Oral Dis, 7, pp.2~10 (2001)
7. Bauer EA, "Collagenase production by human skin fibroblasts", Biochem Biophys Res Commun, 64, pp.232~240 (1975)
8. Gomez DE, "Tissue inhibitors of metalloproteinases: structure, regulation and biological functions", Eur J Cell Biol, 74, pp.111~122 (1997)
9. Young DA, "Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene", Biochem J, 364, pp.89~99 (2002)
10. Muhlemann HR, "Gingival sulcus bleeding : a leading symptom in initial gingivitis", Helv Odontol Acta, 15, pp.107~113 (1971)
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, "Report of the expert committee on the diagnosis and classification of diabetes mellitus", Diabetes Care, 26(1), pp.5~20 (2003)
12. Cho JY, "Expression and activity of human Na+", I-symporter in human glioma cells by adenovirus-mediated gene delivery, 2000, pp.7, 740~749
13. Stefanovic-Racic M, "Nitric oxide and arthritis", Arthritis Rheum, 36, pp.1036~1044 (1993)
14. Allaker RP, "Antimicrobial effect of acidified nitrite on periodontal bacteria", Oral Microbiol Immunol, 16, pp.253~256 (2001)
15. Gyurko R, "Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis", Infect Immun, 71, pp.4917~4924 (2003)
16. Ralston SH, "Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase", Endocrinology, 135, pp.330~336 (1994)
17. van’t Hof RJ, "Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity", J Bone Miner Res, 12, pp.1797~1804 (1997)
18. Lohinai Z, "Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat", Br J Pharmacol, 123, pp.353~360 (1998)
19. Leitão RF, "Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats", J Periodontol, 76, pp.956~963 (2005)
20. Lin SK, "Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts", J Bone Miner Res, 18, pp.39~46 (2003)
21. Alayan J, "Deficiency of iNOS contributes to Porphyromonas gingivalis-induced tissue damage", Oral Microbiol Immunol, 21, pp.360~365 (2006)
22. Takahashi Y, "Increased induction of inducible nitric oxide synthase expression in aortae of type 2 diabetes rats", J Pharmacol Sci, 107, pp.190~200 (2008)
23. Pereira FO, "Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type 2 diabetes mellitus", Mediators Inflamm, 2006, pp.39062~ (2006)
24. Nagareddy PR, "Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats", Eur J Pharmacol, 611, pp.53~59 (2009)
25. Kashyap SR, "Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects", J Clin Endocrinol Metab, 90, pp.1100~1105 (2005)
26. Lappin DF, "Inducible nitric oxide synthase expression in periodontitis", J Periodontal Res, 35, pp.369~373 (2000)
27. Nishikawa T, "Involvement of nitrosative stress in experimental periodontitis in diabetic rats", J Clin Periodontol, 39, pp.342~349 (2012)
28. Garlet GP, "The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis : host protection and tissue destruction", Clin Exp Immunol, 147, pp.128~138 (2007)
29. Garlet GP, "Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease", J Clin Periodontol, 31, pp.671~679 (2004)
30. Kubota T, "Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue", J Periodontol, 79, pp.166~173 (2008)
31. Nakasone N, "Differential gene and protein expression of tissue inhibitors of metalloproteinases(TIMP)-3 and TIMP-4 in gingival tissues from drug induced gingival overgrowth", Arch Oral Biol, 54, pp.634~641 (2009)
32. Claudino M, "The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome", J Leukoc Biol, 84, pp.1565~1573 (2008)
33. Nagase H, "Matrix metalloproteinases", J Biol Chem, 274, pp.21491~21494 (1999)
34. Garlet GP, "Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors", Oral Microbiol Immunol, 21, pp.12~20 (2006)
35. Cochran DL, "Inflammation and bone loss in periodontal disease", J Periodontol, 79(8), pp.1569~1576 (2008)
36. Amour A, "TNF-alpha converting enzyme(TACE)is inhibited by TIMP-3", FEBS Lett, 435, pp.39~44 (1998)
37. Monroy A, "Impaired regulation of the TNF-alpha converting enzyme", tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients : a new mechanism of insulin resistance in humans, 2009, pp.52, 2169~2181
38. Cardellini M, "TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1", Diabetes, 58, pp.2396~2401 (2009)
39. Koskivirta I, "Tissue inhibitor of metalloproteinases 4(TIMP4)is involved in inflammatory processes of human cardiovascular pathology", Histochem Cell Biol, 126, pp.335~342 (2006)

관련 논문AI추천